Kanglaite injection enhances the efficacy of cisplatin in suppressing HCC cells by inhibiting the CKLF1-mediated NF-κB pathway and regulating transporter-mediated drug efflux [66]. Here, CKLF is linked to hepatocellular carcinoma.